Overdose Reversal Drug Maker Settles FCA Suit For $12.7M
Virginia-based pharmaceutical firm Kaléo Inc. will pay the federal government more than $12.7 million to settle claims that it conspired with doctors and pharmacies to skirt federal insurers' authorization requirements before...To view the full article, register now.
Already a subscriber? Click here to view full article